Skip to main content

Table 4 Intention to treat analysis

From: Evaluation of a modified clinical prediction rule for use with spinal manipulative therapy in patients with chronic low back pain: a randomized clinical trial

mCPR status treatment group time of measurement

Outcome measures

VASa

ODIb

SF-36 Painc

(St. Dev.)

(St. Dev.)

(St. Dev.)

Negative on mCPR

SMT (n = 32)

 Baseline

58.44 (15.46)

35.13 (8.55)

5.56 (1.20)

 5-weeks

37.51 (28.89)

29.01 (14.66)

6.98 (1.66)

 12-weeks

43.29 (24.62)

32.14 (15.77)

6.41 (1.92)

 24-weeks

47.61 (25.66)

30.17 (15.69)

6.60 (2.06)

AET (n = 28)

 Baseline

65.36 (16.78)

37.04 (12.57)

5.35 (1.21)

 5-weeks

36.50 (33.77)

30.15 (17.71)

6.56 (2.33)

 12-weeks

42.00 (33.57)

32.91 (20.82)

6.54 (2.72)

 24-weeks

52.54 (27.24)

32.71 (18.64)

6.44 (2.47)

Positive on mCPR

SMT (n = 60)

 Baseline

61.25 (13.74)

33.62 (9.60)

5.78 (1.22)

 5-weeks

34.86 (31.18)

26.71 (15.06)

7.10 (2.22)

 12-weeks

40.43 (27.53)

29.64 (18.30)

6.57 (2.55)

 24-weeks

38.47 (26.99)

23.16 (15.74)

7.51 (2.71)

AET (n = 61)

 Baseline

55.38 (16.64)

31.44 (10.05)

6.00 (1.52)

 5-weeks

26.60 (33.48)

23.73 (17.14)

7.49 (2.57)

 12-weeks

36.30 (29.64)

25.94 (19.90)

7.05 (2.98)

 24-weeks

42.11 (31.77)

23.52 (18.98)

7.75 (3.08)

  1. athe higher the number the higher the reported pain on a 100 point scale.
  2. bthe higher the number the more disability reported due to pain on a 100 point scale.
  3. cthe higher the number the less self-reported pain on the computed SF-36 pain subscale.